MLTX INVESTIGATION NOTICE: BFA Law Notifies MoonLake Immunotherapeutics Investors of Pending Securities Fraud Investigation for Investors seeking Recovery

New York, New York--(Newsfile Corp. - October 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ: MLTX) for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics.Why Is MoonLake being Investigated?MoonLake is a clinical stage biotechnology company focusing on therapies to addres ...